Summary
The vascular endothelial growth factor (VEGF) family is a novel regulator of endothelial cell proliferation. We assessed the mRNA expression of VEGF, VEGF type C (VEGF-C) and their receptors together with the microvessel density (VD) and microlymphatic vessel density (LVD) in pursuit of their connection and prognostic value in malignant pleural mesothelioma (MPM). We used four human MPM cell lines, 54 MPM tumours and five normal pleural tissues. Expression levels for receptors and ligands were assessed by semiquantitative reverse transcriptase polymerase chain reaction analysis. Microvessels were highlighted by immunohistochemical staining for factor VIII. The discrimination of lymphatics was performed by enzyme-histochemistry for 5′-nucleotidase after adequate inhibition of non-specific activity. The expression levels of VEGF, VEGF-C and VEGFRs were high in all MPM cell lines. The percentages of tumours with higher expression compared to the mean values of normal pleural tissues were 31.5% (17/54) for VEGF, 66.7% (36/54) for VEGF-C, 20.4% (11/54) for fms-like tyrosine kinase (flt)-1, 42.6% (23/54) for kinase insert domain-containing recepter (KDR) and 59.3% (32/54) for flt-4. Significant positive correlations were found between VEGF-C and flt-4, VEGF and KDR, VEGF and flt-1 in tumour tissues. The association between LVD and VEGF-C expression level was especially strong (P < 0.0001, r = 0.63). There were also significant correlations between LVD and flt-4, and VD and VEGF. No correlation, however, was found between LVD and nodal metastasis. VD was a negative prognostic indicator in this study. The associations between VEGF/VEGF-C and vessel density suggest that these factors play an important role in angiogenesis and lymphangiogenesis in this tumour, and assessment of vascularity may be a useful prognostic indicator for MPM patients.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Airas, L, Niemela, J, Salmi, M, Puurunen, T, Smith, DJ & Jalkanen, S (1997). Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol 136: 421–431.
Canbolat, O, Durak, I, Cetin, R, Kavutcu, M, Demirci, S & Ozturk, S (1996). Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cystidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Cancer Res Treat 37: 189–193.
Chodak, GW, Haudenschild, C, Gittes, RF & Folkman, J (1980). Angiogenic activity as a marker of neoplasia and preneoplasia in lesions of the human bladder. Ann Surg 192: 762–771.
Durak, I, Beduk, Y, Kavutcu, M, Suzer, O, Yaman, O, Ozturk, HS, Canbolat, O & Ulutepe, S (1997). Activity of the enzymes participating in purine metabolism of cancerous and non-cancerous human kidney tissues. Cancer Invest 5: 212–216.
Folkman, J (1990). What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82: 4–6.
Folkman, J (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27–31.
Grimmond, S, Lagercrantz, J, Drinkwater, C, Silins, G, Townson, S, Pollock, P, Gotley, D, Carson, E, Rakar, S, Nordenskjold, M, Ward, L, Hayward, N & Weber, G (1996). Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res 6: 124–131.
Hewett, PW & Murray, JC (1996). Coexpression of flt-1, flt-4 amd KDR in freshly isolated and cultured human endothelial cells. Biochem Biophys Res Commun 221: 697–702.
Jeltsch, M, Kaipainen, A, Joukov, V, Meng, X, Lakso, M, Rauvala, H, Swartz, M, Fukumura, D, Jain, RK & Alitalo, K (1997). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423–1425.
Ji, RC & Kato, S (1997). Enzyme-histochemical study on postnatal development of rat stomach lymphatic vessels. Microvasc Res 54: 1–12.
Joukov, V, Pajusola, K, Kaipainen, A, Chilov, D, Lahtinen, I, Kukk, E, Saksela, O, Kalkkinen, N & Alitalo, K (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290–298.
Kaipainen, A, Korhonen, J, Mustonen, T, van Hinsbergh, VWM, Fang, G, Dumont, D, Breitman, M & Alitalo, K (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566–3570.
Kukk, E, Lymboussaki, A, Taira, S, Kaipainen, A, Jeltsch, M, Joukov, V & Alitalo, K (1996). VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829–3837.
Kumar-Singh, S, Vermeulen, PB, Weyler, J, Segers, K, Weyn, B, van Daele, A, Dirix, LY, van Oosterom, AT & van Marck, E (1997). Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma. J Pathol 182: 211–216.
Lee, J, Gray, A, Yuan, J, Luoh, S, Avraham, H & Wood, WI (1996). Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor flt-4. Proc Natl Acad Sci USA 93: 1988–1992.
Macchiarini, P, Fontanini, G, Hardin, MJ, Squartini, F & Angeletti, CA (1992). Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340: 145–146.
Mattern, J, Koomagi, R & Volm, M (1995). Vascular endothelial growth factor expression and angiogenesis in non-small-cell lung carcinomas. Int J Oncol 6: 1059–1062.
Meyer, M, Clauss, M, Lepple-Wienhues, A, Waltenberger, J, Augustin, HG, Ziche, M, Lanz, C, Bittner, M, Rziha, HJ & Dehio, C (1999). A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinase. EMBO J 18: 363–374.
Mossman, BT, Kamp, DW & Weitzman, SA (1996). Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 14: 466–480.
Oh, SJ, Jeltsch, MM, Birkenhager, R, McCarthy, JE, Weich, HA, Christ, B, Alitalo, K & Wilting, J (1997). VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188: 96–109.
Olofsson, B, Pajusola, K, Kaipainen, A, von Euler, G, Joukov, V, Saksela, O, Orpana, A, Pettersson, RF, Alitalo, K & Eriksson, U (1996). Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93: 2576–2581.
Pass, HI, Stevens, EJ, Oie, H, Tsokos, MG, Abati, AD, Fetsch, PA, Mew, DJY, Pogrebniak, HW & Matthews, WJ (1995). Characteristics of nine newly derived mesothelioma cell lines. Ann Thorac Surg 59: 835–8344.
Rusch, VW (1996). A proposed new International TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 14: 1–12.
Samoto, K, Ikezaki, K, Ono, M, Shono, T, Kohno, K, Kuwano, M & Fukui, M (1995). Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumor. Cancer Res 55: 1189–1193.
Takahashi, Y, Kitadai, Y, Bucana, CD, Cleary, KR & Ellis, LM (1995). Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964–3968.
Toi, M, Hoshina, S, Takayanagi, T & Tominaga, T (1994). Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045–1049.
Turner, RR, Beckstead, JH, Warnke, RA & Wood, GS (1987). Endothelial cell phenotypic diversity. In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes. Am J Clin Pathol 87: 569–575.
Vetter, W (1970). Alkaline phosphatasen in mastzellen, blut- und lymphagefäβen der rattenzunge. 5′-nucleotidase-, unspezifische alkalische phosphatase- und polyphosphatase- (ATP′ase) aktivität unter besondere berückscichtigung des pH. Z Anat Entwicklungsgesch 130: 153–176.
Wachstein, M & Meisel, E (1954). The histochemical distribution of 5-nucleotidase and unspecific alkaline phosphatase in the testicle of various species and in two human seminomas. J Histochem 2: 137–148.
Weidner, N, Semple, JP, Welch, WR & Folkman, J (1991). Tumor angiogenesis and metastasis – correlation in invasive breast carcinoma. N Engl J Med 324: 1–8.
Wilting, J, Birkenhager, R, Eichmann, A, Kurz, H, Martiny-Baron, G, Marme, D, McCarthy, JE, Christ, B & Weich, HA (1996). VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Dev Biol 176: 76–85.
Wood, GS, Beckstead, JH, Turner, RR, Hendrickson, MR, Kempson, RL & Warnke, RA (1986). Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol 110: 323–335.
Yamada, Y, Nezu, J, Shimane, M & Hirata, Y (1997). Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42: 483–488.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ohta, Y., Shridhar, V., Bright, R. et al. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer 81, 54–61 (1999). https://doi.org/10.1038/sj.bjc.6690650
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690650
Keywords
This article is cited by
-
High-Risk Peritoneal Mesothelioma: Does Metronomic Chemotherapy Have a Role?
Indian Journal of Surgical Oncology (2023)
-
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
Targeted Oncology (2022)
-
Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells
Oncogene (2017)